Latest filing published 23 Jun 2026 for Revolution Medicines, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Flavia Borellini: trading record in brief
This profile gathers the share dealings of Flavia Borellini in Revolution Medicines, Inc., where the filings describe the role as board member. We count 7 filings; the first trade dates from 22 June 2021 and the latest from 18 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 23 June 2026 came the latest disclosure, a share grant in Revolution Medicines, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Flavia Borellini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,191 sharesCommon StockSEC:0001610717-26-000281:0
- 3,142 shares0Common StockSEC:0001610717-25-000269:0
- 4,248 shares0Common StockSEC:0001610717-24-000378:0
- 4,800 shares0Common StockSEC:0001610717-24-000357:0
- 5,200 shares0Common StockSEC:0001610717-23-000136:0
- 5,200 shares0Common StockSEC:0001567619-22-013112:0
- 7,234 shares0Common StockSEC:0001567619-21-012592:0
7 of 7 declarations
